# Multicenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural Mesothelioma

> **NCT06875076** · PHASE2 · RECRUITING · sponsor: **The First Hospital of Jilin University** · enrollment: 25 (estimated)

## Conditions studied

- Pretreated Pleural Mesothelioma

## Interventions

- **DRUG:** Ivonescimab Combined With Chemotherapy

## Key facts

- **NCT ID:** NCT06875076
- **Lead sponsor:** The First Hospital of Jilin University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-08
- **Primary completion:** 2028-01
- **Final completion:** 2029-12
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2025-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06875076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06875076, "Multicenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural Mesothelioma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06875076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*